CAMBRIDGE, Mass., Feb. 27, 2017 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the
Cowen and Company 37th Annual Healthcare Conference on
Monday, March 6, 2017, at
4:00 p.m. ET in Boston, MA. A live webcast of Infinity's
presentation will be accessible on the Investors/Media section of
Infinity's website at www.infi.com, and will be available for 30
days following the event.
About Infinity
Infinity is an innovative
biopharmaceutical company dedicated to advancing novel medicines
for people with cancer. Infinity is advancing IPI-549, an oral
immuno-oncology development candidate that selectively inhibits
PI3K-gamma. A Phase 1 study in patients with advanced solid tumors
is ongoing. For more information on Infinity, please refer to
Infinity's website at www.infi.com.
Contact:
Jaren Irene
Madden, Senior Director,
Investor Relations and Corporate Communications
617-453-1336 or Jaren.Madden@infi.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/infinity-to-present-at-37th-annual-cowen-and-company-healthcare-conference-300413327.html
SOURCE Infinity Pharmaceuticals, Inc.